Core Laboratories/$CLB
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Ticker
$CLB
Sector
Primary listing
NYSE
Employees
3,300
Headquarters
Website
CLB Metrics
BasicAdvanced
$720M
22.74
$0.68
1.38
$0.04
0.26%
Price and volume
Market cap
$720M
Beta
1.38
52-week high
$21.09
52-week low
$9.72
Average daily volume
654K
Dividend rate
$0.04
Financial strength
Current ratio
2.37
Quick ratio
1.419
Long term debt to equity
56.105
Total debt to equity
60.241
Dividend payout ratio (TTM)
5.83%
Interest coverage (TTM)
4.48%
Profitability
EBITDA (TTM)
62.058
Gross margin (TTM)
19.95%
Net profit margin (TTM)
6.21%
Operating margin (TTM)
9.34%
Effective tax rate (TTM)
25.98%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
4.97%
Return on equity (TTM)
12.26%
Valuation
Price to earnings (TTM)
22.737
Price to revenue (TTM)
1.394
Price to book
2.63
Price to tangible book (TTM)
11.21
Price to free cash flow (TTM)
20.971
Free cash flow yield (TTM)
4.77%
Free cash flow per share (TTM)
0.737
Dividend yield (TTM)
0.26%
Forward dividend yield
0.26%
Growth
Revenue change (TTM)
-1.02%
Earnings per share change (TTM)
25.86%
3-year revenue growth (CAGR)
2.02%
10-year revenue growth (CAGR)
-5.31%
3-year earnings per share growth (CAGR)
27.27%
10-year earnings per share growth (CAGR)
-15.86%
10-year dividend per share growth (CAGR)
-32.86%
What the Analysts think about CLB
Analyst ratings (Buy, Hold, Sell) for Core Laboratories stock.
Bulls say / Bears say
Core Laboratory’s Q2 2025 revenue rose to $130.2 million, a 5 percent sequential increase, showing strong quarter-over-quarter demand recovery. (PRNewswire)
Core Lab increased its Q2 2025 operating margins (excluding special items) to 11 percent, a sequential improvement of 160 basis points, reflecting stronger operating leverage. (PRNewswire)
On October 1, 2025, Core Laboratories finalized its acquisition of Brazil-based Solintec for an initial cash payment of $2.3 million, expanding its presence in South Atlantic Margin geological services and expected to be immediately accretive. (Seeking Alpha)
Core Lab’s Q3 2025 revenue of $134.5 million was unchanged from a year ago, showing little top-line growth compared to the same period last year. (Seeking Alpha)
Operating income (excluding special items) for Q3 2025 fell 9 percent year-over-year to $16.6 million, highlighting ongoing margin pressure despite sequential improvement. (Seeking Alpha)
Core’s Q3 2025 earnings per share (excluding special items) dropped 12 percent compared to the prior year to $0.22, pointing to continued challenges in bottom-line performance. (Seeking Alpha)
Data summarised monthly by Lightyear AI. Last updated on 10 Nov 2025.
CLB Financial Performance
Revenues and expenses
CLB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Core Laboratories stock?
Core Laboratories (CLB) has a market cap of $720M as of November 12, 2025.
What is the P/E ratio for Core Laboratories stock?
The price to earnings (P/E) ratio for Core Laboratories (CLB) stock is 22.74 as of November 12, 2025.
Does Core Laboratories stock pay dividends?
Yes, the Core Laboratories (CLB) stock pays dividends to shareholders. As of November 12, 2025, the dividend rate is $0.04 and the yield is 0.26%. Core Laboratories has a payout ratio of 5.83% on a trailing twelve-month basis.
When is the next Core Laboratories dividend payment date?
The next Core Laboratories (CLB) dividend payment is scheduled for November 24, 2025.
What is the beta indicator for Core Laboratories?
Core Laboratories (CLB) has a beta rating of 1.38. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.